Alpine Immune Sciences, Inc. EPS - Earnings per Share 2013-2024 | ALPN
Alpine Immune Sciences, Inc. eps - earnings per share from 2013 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Alpine Immune Sciences, Inc. Annual EPS |
| 2023 |
$-0.64 |
| 2022 |
$-1.73 |
| 2021 |
$-1.98 |
| 2020 |
$-1.34 |
| 2019 |
$-2.28 |
| 2018 |
$-2.63 |
| 2017 |
$-1.20 |
| 2016 |
$-2.18 |
| 2015 |
$-0.74 |
| 2014 |
$-81.08 |
| 2013 |
$-418.00 |
| 2012 |
$-278.80 |
| 2011 |
$0.00 |
| 2010 |
$0.00 |
| 2009 |
$0.00 |
| Alpine Immune Sciences, Inc. Quarterly EPS |
| 2024-03-31 |
$-0.28 |
| 2023-12-31 |
$0.15 |
| 2023-09-30 |
$-0.24 |
| 2023-06-30 |
$-0.27 |
| 2023-03-31 |
$-0.28 |
| 2022-12-31 |
$-0.46 |
| 2022-09-30 |
$-0.42 |
| 2022-06-30 |
$-0.60 |
| 2022-03-31 |
$-0.25 |
| 2021-12-31 |
$-0.52 |
| 2021-09-30 |
$-0.55 |
| 2021-06-30 |
$-0.46 |
| 2021-03-31 |
$-0.45 |
| 2020-12-31 |
$-0.23 |
| 2020-09-30 |
$-0.28 |
| 2020-06-30 |
$-0.53 |
| 2020-03-31 |
$-0.30 |
| 2019-12-31 |
$-0.32 |
| 2019-09-30 |
$-0.62 |
| 2019-06-30 |
$-0.64 |
| 2019-03-31 |
$-0.70 |
| 2018-12-31 |
$-0.80 |
| 2018-09-30 |
$-0.88 |
| 2018-06-30 |
$-0.57 |
| 2018-03-31 |
$-0.38 |
| 2017-12-31 |
$7.25 |
| 2017-09-30 |
$0.18 |
| 2017-06-30 |
$-5.40 |
| 2017-03-31 |
$-3.23 |
| 2016-12-31 |
$2.67 |
| 2016-09-30 |
$-0.61 |
| 2016-06-30 |
$-2.20 |
| 2016-03-31 |
$-2.04 |
| 2015-12-31 |
$14.26 |
| 2015-09-30 |
$-1.56 |
| 2015-06-30 |
$-5.64 |
| 2015-03-31 |
$-7.80 |
| 2014-12-31 |
$160.56 |
| 2014-09-30 |
$-30.72 |
| 2014-06-30 |
$-102.80 |
| 2014-03-31 |
$-108.12 |
| 2013-12-31 |
$0.00 |
| 2012-12-31 |
$0.00 |
